Skip to content

CHOICE: CHOosing treatment together In Cancer at the End of life

CHOICE: CHOosing treatment together In Cancer at the End of life - CHOICE: CHOosing treatment together In Cancer at the End of life

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON44961
Enrollment
192
Registered
2015-08-11
Start date
2016-03-01
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uitgezaaide, niet-operabele tumoren Metastasized and inoperable tumours

Interventions

The CHOICE skills training is based on a four-step model of SDM and on techniques known from behavior change theories. The training is provided in small groups (n=3-5) by a professional trainer and

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients In order to be eligible to participate in this study, a subject must meet all of the following criteria: 1. diagnosed with metastasized or locally irresectable cancer 2. not eligible for treatment with curative intent 3. median life expectancy of

Exclusion criteria

Exclusion criteria: Patients A potential subject who meets any of the following criteria will be excluded from participation in this study: 1. insufficient mastery of Dutch, i.e., inability to understand the 'Gesprekswijzer' as well as the questionnaires as judged by either the physician or the researcher 2. cognitive disabilities or a psychiatric disorder that hinder understanding of the 'Gesprekswijzer' as well as the questionnaires as judged by either the physician or the researcher 3. not enough time (

Design outcomes

Primary

MeasureTime frame
The primary outcome is the level of SDM as observed in the consultation. To this end, we will audiotape the consultation.

Secondary

MeasureTime frame
o Observed SDM in a simulated patient encounter (effect training only) o Patients* perceived efficacy in communication before the consultation o Patient and oncologist satisfaction with communication and decision making o Congruence between patients* preferred and perceived role in decision making o Patients* attitudes towards striving for quantity (length) or quality of life o Patients* evaluation of the decision made o Patients* quality of life o Patients* trust in the oncologist o Patients* anxiety o Patients* fighting spirit o Consultation time o The treatment decision made o Patients* use of the *Gesprekswijzer* o Patients*evaluation of the *Gesprekswijzer*

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)